Skip to main content
. Author manuscript; available in PMC: 2022 Mar 10.
Published in final edited form as: Zoonoses. 2022 Feb 8;2(1):6. doi: 10.15212/zoonoses-2022-0001

Table 1.

Notable mutations that benefit the infectivity, transmissibility and immune escape of SARS-CoV-2.

Mutations Locations Representative Lineages Functions References
S13I N-terminal domain B.1.427 Immune escape [25]
L18F N-terminal domain Beta, Gamma Immune escape [26]
del69-70 N-terminal domain Alpha, Omicron* Immune escape/Increase transmissibility [27]
W152C N-terminal domain B.1.427 Immune escape [25]
K417N/T Receptor binding domain Beta, Gamma, Omicron Attenuate biding affinity to ACE2/Immune escape [28]
N439K Receptor binding domain AV.1 Increase binding affinity to ACE2/immune escape [29]
N440K Receptor binding domain Omicron Increase infectivity [30]
L452R Receptor binding domain Delta Immune escape [31-33]
Y453F Receptor binding domain Delta Immune escape [34]
S477G/N/R Receptor binding domain Omicron Immune escape [35]
E484K/Q/P Receptor binding domain Beta, Gamma, Delta, Eta, Lota, Kappa, Mu, Omicron Immune escape [31,32]
S494P Receptor binding domain Alpha immune escape [36,37]
N501Y Receptor binding domain Alpha, Beta, Gamma, Mu, Omicron Increase infection and transmissibility [7,28]
D614G S1 domain-C terminal All lineages Increase infectivity [22]
H655Y Close to S1/S2 cleavage site Gamma, Omicron Immune escape [38]
P681H/R Close to S1/S2 cleavage site Alpha, Kappa, Mu, Omicron Increase cleavage efficiency [10]
*

Omicron is underlined to indicate multiple mutations and deletions from other variants.